Unternehmen Caplin Point Laboratories Limited NSE India S.E.
Aktien
A2DSTM
INE475E01026
CAPLIPOINT
Pharmazeutika
Verzögert
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
1’423 INR | +0.17% |
|
+3.04% | +5.00% |
Kurzporträt
Mitarbeiterzahl: 1 642
Umsatz nach Geschäftsbereich
INR in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
Pharmaceutical
100,0
%
| 12 694 | 100,0 % | 14 667 | 100,0 % | +15.54% |
Umsatz je Region
INR in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
Latin America
83,0
%
| 11 381 | 87,0 % | 12 638 | 83,0 % | +11.05% |
United States
14,0
%
| 1 308 | 10,0 % | 2 132 | 14,0 % | +62.96% |
Africa
3,0
%
| 392 | 3,0 % | 457 | 3,0 % | +16.40% |
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Sridhar Ganesan
CEO | Chief Executive Officer | 69 | 28.03.15 |
D. Muralidharan
DFI | Director of Finance/CFO | - | 19.02.16 |
Anto V.
ADM | Chief Administrative Officer | - | - |
Gunasakaran S.
CTO | Chief Tech/Sci/R&D Officer | - | - |
Umesh Setty V.
CTO | Chief Tech/Sci/R&D Officer | - | - |
Compliance Officer | - | 25.06.22 | |
Chief Operating Officer | - | 01.12.10 | |
Umapathy V.
LAW | General Counsel | - | - |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Chairman | 71 | - | |
Chief Operating Officer | - | 01.12.10 | |
Sridhar Ganesan
CEO | Chief Executive Officer | 69 | 28.03.15 |
Director/Board Member | 65 | 09.11.16 | |
C. K. Gariyali
BRD | Director/Board Member | 75 | 04.03.20 |
R. Nagendran
BRD | Director/Board Member | - | - |
S Deenadhayalan
BRD | Director/Board Member | - | - |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 76 010 296 | 19 309 473 ( 25,40 %) | 0 | 25,40 % |
Unternehmenskontakt
Caplin Point Laboratories Ltd.
Ashvich Tower Developed Plots Industrial Estate
600096, Chennai
+91 44 2496 8000
http://www.caplinpoint.net![Straße Caplin Point Laboratories Limited(CAPLIPOINT)](https://cdn.zonebourse.com/static/address/31670633.png)
Konzerngesellschaften
Name | Kategorie und Branche |
---|---|
Caplin Steriles Ltd.
![]() Caplin Steriles Ltd. Pharmaceuticals: MajorHealth Technology Caplin Steriles Ltd. manufactures and sells injectable pharmaceutical products. The company was founded on December 12, 2018 and is headquartered in Chennai, India. |
Pharmaceuticals: Major
|
Caplin Onco Ltd.
|
Sektor
Umsatz je Region
![Analystenschätzungen](/images/consensus_flch.gif)
Verlauf des Gewinns je Aktie
Quartalsumsätze - Abweichungsrate
% 1. Jan. | Kap. | |
---|---|---|
+18.00% | 42.2 Mrd. | |
+22.18% | 21.24 Mrd. | |
+21.73% | 15.89 Mrd. | |
+25.25% | 14.91 Mrd. | |
+59.29% | 13.1 Mrd. | |
-0.05% | 6.79 Mrd. | |
-14.92% | 6.24 Mrd. | |
+21.38% | 6.08 Mrd. | |
-8.87% | 5.73 Mrd. |
- Börse
- Aktien
- A2DSTM Aktie
- A2DSTM Aktie
- Unternehmen Caplin Point Laboratories Limited